ESC 2024 Insights: WITHDRAWal of Heart Failure Pharmacotherapy in Patients with Normalized Left Ventricular Function After AF Rhythm Control in Arrhythmia Induced Cardiomyopathy-The WITHDRAW-AF Randomized Clinical Trial

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

10 seconds

Playback speed

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

ESC 2024 Insights: WITHDRAWal of Heart Failure Pharmacotherapy in Patients with Normalized Left Ventricular Function After AF Rhythm Control in Arrhythmia Induced Cardiomyopathy-The WITHDRAW-AF Randomized Clinical Trial

By ESC 2024 Insights FEATURING Louise Segan

2,053 views

November 7, 2024

Comments 0

Improving Cardiovascular Outcomes: The New Era of Prevention (Hybrid…

Thu, Jun 12, 2025

29th Annual Heart Failure 2025: An Update on Therapy

Sat, May 3, 2025

The American Society for Preventive Cardiology

ASPC 2025 Congress on CVD Prevention

Fri, Aug 1, 2025

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

ACC 2022 Conference Coverage

P. Heidenreich

24.3K views

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

23.2K views

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

MUSC Cardiology

R. Mentz

15.0K views

How I Manage Patients with Frequent PVCs

Stanford Medicine

R. John

11.5K views

Top 5 Arrhythmias You Need to Know

Joel Gorfinkel

8.3K views

AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…

AHA 2022 Conference Coverage

R. Mentz

7.6K views

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …

Michelle Kittleson

6.4K views

Rhythm vs Rate: Has the Tide Changed Since the AFFIRM Trial?

The Texas Heart Institute

M. Razavi

6.7K views

Management of Heart Failure

Obafemi Awolowo University

O. A. Akinyele

619 views

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Scripps Health

M. Kittleson

5.6K views

Postural Tachycardia Syndrome: Pathophysiology and Impact of Tragus …

Virtual EP Connect

V. Reddy, F. Marchlinski, T. Glotzer, B. Olshansky, S. Po, S. Stavrakis

6.0K views

Cardiac Amyloidosis: A New Era of Diagnostics and Therapeutics

UCLA Health

D. Vucicevic

265 views

Benefits of Slowing the Heart with Ivabradine

San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

40 views

Hot Topics in Heart Failure ACC.22

ACC 2022 Conference Coverage

N. Ibrahim

3.5K views

Weight Loss as Treatment for HFpEF: An Update on Drugs and Procedures

MUSC Cardiology

S. Litwin

276 views

ACC 2024 Insights: Stop the Meds! Treat the Comorbidities for Optima…

ACC 2024 Insights

K. Williams

3.2K views

Medical Management of Diastolic Dysfunction: Does The Emperor Finall…

Top Ten Topics in Clinical Cardiology 2023

S. Pinney

3.4K views

Digoxin Update 2023: Are the Current Digoxin Monitoring Guidelines H…

Mary E. Money

3.2K views

Esmolol in Refractory VF

The 9th Annual Western New England Acute Cardiology Conference

B. Hoffman

94 views

Precision Medicine in Menopause: How Times Have Changed!

Right Care Initiative

K. Adams

2.8K views

AUTOPLAY

Login

Login

Join VuMedi

ESC 2024 Insights: WITHDRAWal of Heart Failure Pharmacotherapy in Patients with Normalized Left Ventricular Function After AF Rhythm Control in Arrhythmia Induced Cardiomyopathy-The WITHDRAW-AF Randomized Clinical Trial

Related Videos

Improving Cardiovascular Outcomes: The New Era of Prevention (Hybrid…

29th Annual Heart Failure 2025: An Update on Therapy

ASPC 2025 Congress on CVD Prevention

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

ACC 2023: SGLT2i Use - Dos and Don'ts

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

How I Manage Patients with Frequent PVCs

Top 5 Arrhythmias You Need to Know

AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …

Rhythm vs Rate: Has the Tide Changed Since the AFFIRM Trial?

Management of Heart Failure

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Postural Tachycardia Syndrome: Pathophysiology and Impact of Tragus …

Cardiac Amyloidosis: A New Era of Diagnostics and Therapeutics

Benefits of Slowing the Heart with Ivabradine

Hot Topics in Heart Failure ACC.22

Weight Loss as Treatment for HFpEF: An Update on Drugs and Procedures

ACC 2024 Insights: Stop the Meds! Treat the Comorbidities for Optima…

Medical Management of Diastolic Dysfunction: Does The Emperor Finall…

Digoxin Update 2023: Are the Current Digoxin Monitoring Guidelines H…

Esmolol in Refractory VF

Precision Medicine in Menopause: How Times Have Changed!